| Barbara Benkiser Mcgrath, NP | |
|
921 S Sherwood Village Dr, Tucson, AZ 85710-5826 | |
| (520) 338-3881 | |
| Not Available |
| Full Name | Barbara Benkiser Mcgrath |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 921 S Sherwood Village Dr, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003499641 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 257101 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Health Care Llc | 3274706593 | 11 |
News Archive
Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7".
Up to now, women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face an unanswered question about whether surgery and radiation to the tumor in the breast (local therapy) will prolong survival compared to the traditional treatment of systemic treatment alone.
The scientists were concerned about the effects that decades of use of antibiotics to treat infections, prevent diseases, or promote growth, have had on the spread of antibiotic resistance genes in common farm bacteria.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the results from a preclinical study showing in vitro and in vivo activity of its first-in-class PRMT5 inhibitor EPZ015666 in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin lymphoma (NHL).
› Verified 5 days ago
| Entity Name | Pinnacle Health Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568793974 PECOS PAC ID: 3274706593 Enrollment ID: O20111102000567 |
News Archive
Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7".
Up to now, women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face an unanswered question about whether surgery and radiation to the tumor in the breast (local therapy) will prolong survival compared to the traditional treatment of systemic treatment alone.
The scientists were concerned about the effects that decades of use of antibiotics to treat infections, prevent diseases, or promote growth, have had on the spread of antibiotic resistance genes in common farm bacteria.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the results from a preclinical study showing in vitro and in vivo activity of its first-in-class PRMT5 inhibitor EPZ015666 in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin lymphoma (NHL).
› Verified 5 days ago
| Entity Name | Green Valley Hospital Medicine Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215604236 PECOS PAC ID: 3779973839 Enrollment ID: O20211203000205 |
News Archive
Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7".
Up to now, women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face an unanswered question about whether surgery and radiation to the tumor in the breast (local therapy) will prolong survival compared to the traditional treatment of systemic treatment alone.
The scientists were concerned about the effects that decades of use of antibiotics to treat infections, prevent diseases, or promote growth, have had on the spread of antibiotic resistance genes in common farm bacteria.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the results from a preclinical study showing in vitro and in vivo activity of its first-in-class PRMT5 inhibitor EPZ015666 in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin lymphoma (NHL).
› Verified 5 days ago
| Entity Name | Green Valley Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720755739 PECOS PAC ID: 4385035534 Enrollment ID: O20211222001498 |
News Archive
Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7".
Up to now, women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face an unanswered question about whether surgery and radiation to the tumor in the breast (local therapy) will prolong survival compared to the traditional treatment of systemic treatment alone.
The scientists were concerned about the effects that decades of use of antibiotics to treat infections, prevent diseases, or promote growth, have had on the spread of antibiotic resistance genes in common farm bacteria.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the results from a preclinical study showing in vitro and in vivo activity of its first-in-class PRMT5 inhibitor EPZ015666 in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin lymphoma (NHL).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Benkiser Mcgrath, NP 921 S Sherwood Village Dr, Tucson, AZ 85710-5826 Ph: (520) 338-3881 | Barbara Benkiser Mcgrath, NP 921 S Sherwood Village Dr, Tucson, AZ 85710-5826 Ph: (520) 338-3881 |
News Archive
Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7".
Up to now, women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face an unanswered question about whether surgery and radiation to the tumor in the breast (local therapy) will prolong survival compared to the traditional treatment of systemic treatment alone.
The scientists were concerned about the effects that decades of use of antibiotics to treat infections, prevent diseases, or promote growth, have had on the spread of antibiotic resistance genes in common farm bacteria.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the results from a preclinical study showing in vitro and in vivo activity of its first-in-class PRMT5 inhibitor EPZ015666 in mantle cell lymphoma (MCL), an aggressive form of non-Hodgkin lymphoma (NHL).
› Verified 5 days ago
Patricia Hiebert, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3870 W River Rd Ste 126, Tucson, AZ 85741 Phone: 520-219-6616 Fax: 520-742-6187 | |
Emily Snavely De La Rosa, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 707 N Alvernon Way, Ste. 101, Tucson, AZ 85711 Phone: 520-694-1640 | |
Mrs. Hazel Echavez Mercado, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10975 E White Sage Dr, Tucson, AZ 85747 Phone: 520-203-7531 Fax: 520-437-0390 | |
Mr. Daniel Leon Ross Jr., NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 600 W Orange Grove Rd Unit A16, Tucson, AZ 85704 Phone: 520-909-3844 Fax: 520-308-5511 | |
Mrs. Diana Verdugo, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 620 N Craycroft Rd, Tucson, AZ 85711 Phone: 520-519-8550 Fax: 520-747-3269 | |
Neva Corbell, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1951 N Wilmot Rd, Bldg 4, Tucson, AZ 85712 Phone: 520-318-1114 Fax: 520-318-4693 | |
Holly Marie Hill, MSN, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2802 E District St, Tucson, AZ 85714 Phone: 520-584-5820 Fax: 520-514-1514 |